SeaSpine (NASDAQ:SPNE) Posts Earnings Results, Misses Estimates By $0.18 EPS
3 min read
SeaSpine (NASDAQ:SPNE – Get Score) posted its quarterly earnings final results on Friday. The medical machines service provider noted ($.52) earnings per share for the quarter, lacking the Zacks’ consensus estimate of ($.34) by ($.18), MarketWatch Earnings experiences. SeaSpine experienced a detrimental return on equity of 20.88% and a negative web margin of 25.18%.
SPNE inventory opened at $12.14 on Monday. SeaSpine has a twelve month minimal of $10.76 and a twelve month superior of $22.97. The organization has a industry capitalization of $442.41 million, a P/E ratio of -8.26 and a beta of 1.19. The firm has a 50 working day basic transferring typical of $12.37 and a 200-working day basic transferring common of $13.98.
SPNE has been the subject matter of a quantity of current analyst reviews. TheStreet lower shares of SeaSpine from a “c-” rating to a “d+” rating in a investigate take note on Tuesday, December 7th. Zacks Financial investment Research reduce shares of SeaSpine from a “buy” rating to a “hold” rating in a research note on Saturday, January 29th. Truist Economical lowered their cost aim on shares of SeaSpine from $25.00 to $20.00 and established a “buy” rating on the inventory in a investigate notice on Tuesday, December 21st. Ultimately, StockNews.com raised shares of SeaSpine from a “sell” rating to a “hold” rating in a investigate notice on Wednesday, March 9th. Two investigation analysts have rated the inventory with a keep rating and 5 have issued a obtain score to the company’s inventory. In accordance to MarketBeat.com, SeaSpine at this time has a consensus ranking of “Buy” and a consensus goal selling price of $35.17.
Various hedge money have lately extra to or lowered their stakes in the company. BNP Paribas Arbitrage SA lifted its stake in SeaSpine by 430.6% for the duration of the third quarter. BNP Paribas Arbitrage SA now owns 6,065 shares of the health-related devices provider’s stock truly worth $95,000 following obtaining an further 4,922 shares in the course of the final quarter. Citigroup Inc. lifted its stake in SeaSpine by 127.2% during the fourth quarter. Citigroup Inc. now owns 8,090 shares of the clinical devices provider’s stock value $110,000 after buying an extra 4,529 shares in the course of the very last quarter. Susquehanna Worldwide Group LLP acquired a new position in SeaSpine throughout the fourth quarter value $163,000. Marshall Wace LLP acquired a new placement in SeaSpine in the course of the fourth quarter truly worth $194,000. Finally, Deutsche Financial institution AG lifted its stake in SeaSpine by 5.3% all through the fourth quarter. Deutsche Bank AG now owns 20,129 shares of the professional medical tools provider’s stock truly worth $275,000 immediately after getting an added 1,012 shares for the duration of the final quarter. 87.19% of the inventory is owned by institutional traders and hedge money.
About SeaSpine (Get Ranking)
SeaSpine Holdings Corp. operates as a health-related engineering corporation. The firm engages in the layout, developmen and commercialization of surgical solutions for the procedure of individuals struggling from spinal issues. It solutions contain thoracolumbar hardware, cervical hardware, orthobiologics, and spine pure strip.
Advisable Stories
Want Far more Fantastic Investing Strategies?
Get News & Rankings for SeaSpine Each day – Enter your email tackle down below to get a concise every day summary of the newest information and analysts’ ratings for SeaSpine and similar organizations with MarketBeat.com’s No cost daily electronic mail publication.
